AddLife AB (publ) (FRA:1AD1)

Market Cap	1.87B +9.6%
Revenue (ttm)	964.87M +1.5%
Net Income	51.75M +122.2%
EPS	0.42 +122.8%
Shares Out	n/a
PE Ratio	36.08
Forward PE	26.55
Dividend	0.07 (0.45%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	n/a
Open	15.09
Previous Close	15.41
Day's Range	15.09 - 15.09
52-Week Range	12.24 - 19.01
Beta	n/a
RSI	75.75
Earnings Date	Apr 1, 2026

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis. It offers products and solutions, including analytical instruments, equipment, microscopes, consumables, and reagents, as w...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1906
• Employees: 2,327
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1AD1

Financial Performance

In 2025, AddLife AB's revenue was 10.44 billion, an increase of 1.52% compared to the previous year's 10.29 billion. Earnings were 560.00 million, an increase of 122.22%.

Financial numbers in SEK